Adinath Bio-Lab Financials

BSE: 590088

₹0.30

₹-0.01 (-3.23%)

As on 07-Mar-2017IST

Market cap

₹7 Cr

Revenue (TTM)

₹-- Cr

P/E Ratio

--

P/B Ratio

0.2

Div. Yield

0 %

Annual
Quarterly

Income Statement (₹ Cr)	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Operating Revenue	--	0.05	0.56	0.81	1.35	1.00
Total Income	0.03	0.54	0.57	1.00	1.42	1.16
Total Expenditure	0.55	1.44	0.42	0.53	0.98	0.73
EBITDA	-0.55	-1.39	0.14	0.27	0.38	0.28
Depreciation	0.01	0.09	0.11	0.16	0.28	0.29
EBIT	-0.56	-1.48	0.03	0.11	0.09	-0.01
Interest	--	--	--	0.00	0.00	0.00
Other Income	0.03	0.49	0.01	0.19	0.07	0.16
Exceptional Items	-1.99	-5.32	--	--	--	--
Profit before Tax	-2.52	-6.30	0.04	0.30	0.16	0.14
Provision for Tax	-0.02	0.73	0.01	0.16	0.00	0.00
Profit after Tax	-2.51	-7.03	0.02	0.14	0.17	0.14

Liabilities (₹ Cr)	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Shareholder's Funds	6.10	8.61	15.64	29.30	29.16	29.18
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.02	0.02	0.01	0.02	0.06
Current Liabilities	0.86	0.92	0.17	0.18	0.14	0.08
Total Liabilities	6.96	9.55	15.82	29.49	29.32	29.32

Assets (₹ Cr)	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Non-Current Assets	5.87	8.32	13.96	28.79	28.77	18.94
Current Assets	1.09	1.23	1.86	0.70	0.55	10.38
Total Assets	6.96	9.55	15.82	29.49	29.32	29.32
Total Debt*	--	--	--	--	--	--
Net Current Assets	0.23	0.31	1.69	0.52	0.41	10.29
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Cash From Operating Activities	-0.01	-0.54	0.12	-2.60	-0.13	-0.06
Cash Flow from Investing Activities	0.02	0.52	-0.17	2.58	0.07	-2.24
Cash from Financing Activities	--	--	--	--	--	2.38
Net Cash Inflow / Outflow	0.01	-0.02	-0.05	-0.02	-0.06	0.08

Financials Ratios	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Adjusted EPS (₹)	-0.11	-0.32	0.00	0.01	0.01	0.01
Cash EPS (₹)	-0.11	-0.31	0.01	0.01	0.02	0.02
Adjusted Book Value (₹)	0.28	0.39	0.71	1.33	1.32	1.32
Dividend per Share (₹)	--	--	--	--	--	--
Cash Flow per Share (₹)	0.00	-0.02	0.01	-0.12	-0.01	0.00
Free Cash Flow per Share (₹)	-0.11	-0.30	0.01	-0.11	0.00	-0.10

Profitability Ratios	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
ROCE (%)	-34.32	-51.97	0.16	1.04	0.56	0.49
ROE (%)	-34.08	-58.01	0.11	0.49	0.57	0.48
ROA (%)	-30.36	-55.45	0.11	0.49	0.56	0.48
EBIT Margin (%)	--	-3,149.43	4.98	13.88	6.92	-1.42
Net Margin (%)	-9,573.48	-1,307.33	4.41	14.41	11.59	12.04
Cash Profit Margin (%)	--	--	24.99	37.81	33.04	42.78

Growth Ratios	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Revenue Growth (%)	-100.00	-91.61	-30.69	-40.45	34.72	-97.66
EBIT Growth (%)	61.94	-5,406.42	-75.13	19.46	757.16	-102.52
Net Profit Growth (%)	64.37	--	-82.62	-12.90	18.07	-79.96
EPS Growth (%)	64.38	--	-82.59	-13.33	19.05	-80.06
Book Value Growth (%)	-29.12	-44.97	-46.63	0.49	-0.08	0.48

Valuation Ratios	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Price / Earnings	--	--	265.08	29.23	25.33	28.57
Price / Book Value	--	--	0.42	0.14	0.14	0.14
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-41.99	-24.55	43.91	8.86	9.17	8.82
Close Price (₹)	--	--	0.30	0.19	0.19	0.18
High Price (₹)	--	--	0.35	0.40	0.54	0.30
Low Price (₹)	--	--	0.19	0.15	0.16	0.16
Market Cap (₹ Cr)	--	--	6.62	4.19	4.19	3.97

Solvency Ratios	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Debt to Equity	--	--	--	--	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	1.27	1.33	11.20	3.96	3.93	124.86
Quick Ratio	1.27	1.33	6.95	3.96	3.93	86.32
Interest Coverage	--	--	--	7,111.72	3,663.36	5,681.10

Operating Efficiency Ratios	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13	Mar-12	Mar-11	Mar-10	Mar-09
Debtors to sales (%)	--	1,324.39	111.16	77.04	33.16	698.92
Asset Turnover	--	0.00	0.02	0.03	0.05	0.03
Receivable days	--	4,834.04	405.72	242.21	1,007.28	2,698.38
Inventory Days	--	--	460.26	--	--	1,171.89
Payable days	--	--	--	--	--	273.23
Cash Conversion Cycle	--	--	--	--	--	3,597.04